[go: up one dir, main page]

NO20090896L - Farmakokinetisk forbedrede forbindelser - Google Patents

Farmakokinetisk forbedrede forbindelser

Info

Publication number
NO20090896L
NO20090896L NO20090896A NO20090896A NO20090896L NO 20090896 L NO20090896 L NO 20090896L NO 20090896 A NO20090896 A NO 20090896A NO 20090896 A NO20090896 A NO 20090896A NO 20090896 L NO20090896 L NO 20090896L
Authority
NO
Norway
Prior art keywords
improved compounds
pharmacokinetically improved
pharmacokinetically
compounds
stereoisomer
Prior art date
Application number
NO20090896A
Other languages
English (en)
Inventor
Steven Kates
Paul Sweetnam
Stewart Campbell
David Duffy
Michael Grogan
Emanuele Ostuni
Olivier Schueller
Original Assignee
Surface Logix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surface Logix Inc filed Critical Surface Logix Inc
Publication of NO20090896L publication Critical patent/NO20090896L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Tilveiebrakt er en forbindelse med formel A som har forbedret uspesifikk bindingskarakteristika og farmakokinetiske egenskaper: (A) eller et farmasøytisk akseptabelt salt, stereoisomer eller hydrat derav.
NO20090896A 2006-08-24 2009-02-26 Farmakokinetisk forbedrede forbindelser NO20090896L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84030606P 2006-08-24 2006-08-24
PCT/US2007/018784 WO2008024494A2 (en) 2006-08-24 2007-08-23 Pharmacokinetically improved compounds

Publications (1)

Publication Number Publication Date
NO20090896L true NO20090896L (no) 2009-03-09

Family

ID=39107450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090896A NO20090896L (no) 2006-08-24 2009-02-26 Farmakokinetisk forbedrede forbindelser

Country Status (15)

Country Link
US (2) US20100324037A1 (no)
EP (2) EP2061322B1 (no)
JP (2) JP2010501577A (no)
KR (1) KR20090042863A (no)
CN (1) CN101528042A (no)
AU (1) AU2007287024A1 (no)
BR (1) BRPI0716571A2 (no)
CA (1) CA2661483A1 (no)
ES (1) ES2548759T3 (no)
IL (1) IL197224A0 (no)
MX (1) MX2009002073A (no)
NO (1) NO20090896L (no)
TW (1) TW200826944A (no)
WO (1) WO2008024494A2 (no)
ZA (1) ZA200901462B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
JP6338601B2 (ja) * 2013-03-01 2018-06-06 フンダシオン パラ ラ インベスティガシオン メディカ アプリカダ ホスホジエステラーゼとヒストンデアセチラーゼの二重阻害剤としての新規な化合物
TW201639851A (zh) * 2015-03-16 2016-11-16 大日本住友製藥股份有限公司 雙環咪唑衍生物
CN114085225A (zh) * 2021-06-04 2022-02-25 广东西捷药业有限公司 一种伐地那非类似物及其合成方法和应用
TWI806144B (zh) * 2021-09-01 2023-06-21 臺灣塑膠工業股份有限公司 纖維預浸布的含浸裝置及其方法
US12258350B1 (en) * 2024-11-14 2025-03-25 Retension Pharmaceuticals, Inc. Crystalline forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5, 1-f][1,2,4]triazin-2-yl)benzenesulfonamide

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0502060A4 (en) 1989-11-13 1993-05-05 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
AU675054B2 (en) 1991-11-22 1997-01-23 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US5359115A (en) 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
JP2857540B2 (ja) 1992-06-22 1999-02-17 ファナック株式会社 カッタパスの自動再作成を行うｃａｄ／ｃａｍ方法及び装置
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
CA2143848C (en) 1992-10-01 2007-09-11 W. Clark Still Complex combinatorial chemical libraries encoded with tags
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
US5440016A (en) 1993-06-18 1995-08-08 Torrey Pines Institute For Molecular Studies Peptides of the formula (KFmoc) ZZZ and their uses
US5362899A (en) * 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
DK1174431T3 (da) * 1997-11-12 2012-08-20 Bayer Pharma AG 2-phenyl-substitueret imidazo triazinon som phoshodiesterase-inhibitorer
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
US6451807B1 (en) * 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
MXPA02006240A (es) * 1999-12-24 2003-01-28 Bayer Ag Nuevas imidazo[1,3,5,) triazinonas y su uso.
US6699665B1 (en) 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone
WO2003012392A2 (en) 2001-07-27 2003-02-13 Surface Logix, Inc. Resealable and sealable devices for biochemical assays
JP2005509737A (ja) 2001-08-27 2005-04-14 サーフェイス ロジックス，インコーポレイティド 単層で被覆された表面への生物学的分子の不動化
DE10162435A1 (de) 2001-12-19 2003-07-17 Joerg Lahann Verfahren zur Erzeugung von Oberflächenbeschichtungen, die die Adsorption von Proteinen bzw. die Adhäsion von Bakterien und/oder Zellen vermindern
JP2005529927A (ja) * 2002-05-23 2005-10-06 ファイザー インコーポレイテッド 新規な組み合わせ
DE102004038328A1 (de) * 2004-08-06 2006-03-16 Bayer Healthcare Ag Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten
EP1848437A4 (en) * 2005-02-18 2012-04-25 Surface Logix Inc METHOD FOR PRODUCING PHARMACOKINETIC IMPROVED COMPOUNDS WITH FUNCTIONAL RESTORATIONS OR GROUPS AND PHARMACEUTICAL COMPOSITIONS WITH THESE COMPOUNDS
CR9465A (es) * 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente

Also Published As

Publication number Publication date
ES2548759T3 (es) 2015-10-20
MX2009002073A (es) 2009-05-25
KR20090042863A (ko) 2009-04-30
WO2008024494A9 (en) 2009-04-02
EP2705753A1 (en) 2014-03-12
CA2661483A1 (en) 2008-02-28
US20130096114A1 (en) 2013-04-18
CN101528042A (zh) 2009-09-09
AU2007287024A1 (en) 2008-02-28
TW200826944A (en) 2008-07-01
EP2061322A4 (en) 2011-01-05
JP2014055136A (ja) 2014-03-27
WO2008024494A2 (en) 2008-02-28
ZA200901462B (en) 2010-07-28
WO2008024494A3 (en) 2008-04-10
JP2010501577A (ja) 2010-01-21
EP2061322A2 (en) 2009-05-27
IL197224A0 (en) 2009-12-24
EP2061322B1 (en) 2015-07-01
BRPI0716571A2 (pt) 2013-11-05
US8853394B2 (en) 2014-10-07
US20100324037A1 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
EA200970856A1 (ru) Ингибиторы пути хеджхога
WO2007105058A8 (en) Pyrazole compounds
EA201000113A1 (ru) Пиразольные соединения
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
NO20076498L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
NO20080761L (no) Acykliske Ikur inhibitorer
EA201001848A1 (ru) Производные пиразина в качестве блокаторов эпителиальных натриевых каналов
WO2010014836A3 (en) Tgr5 modulators and methods of use thereof
NO20063501L (no) Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
DK2114933T3 (da) Piperidin-GPCR-agonister
ATE557024T1 (de) Piperidinverbindungen als gpcr-agonisten
WO2007003962A3 (en) Gpcr agonists
WO2007003961A3 (en) Gpcr agonists
EA201170617A1 (ru) Пиразолиламинопиридины в качестве ингибиторов fak
ATE557023T1 (de) Piperidinylverbindungen als gpcr-agonisten
NO20090896L (no) Farmakokinetisk forbedrede forbindelser
NO20084583L (no) Makrosykliske kinase-inhibitorer
MA32977B1 (fr) Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol
GEP20125712B (en) Method for preparation of piperazine compounds and hydrochloride salts thereof
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
EA200970041A1 (ru) Ингибиторы акт (протеинкиназы в)
EA200801199A1 (ru) Ингибиторы киназы
TW200740814A (en) Compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application